Published in Med Microbiol Immunol on December 18, 2007
Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study. Am J Epidemiol (2010) 1.85
Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies. Virol J (2009) 1.17
Stereoselective phosphorylation of cyclopropavir by pUL97 and competitive inhibition by maribavir. Antimicrob Agents Chemother (2010) 1.15
Rapid quantitation of cytomegalovirus DNA in whole blood by a new molecular assay based on automated sample preparation and real-time PCR. Med Microbiol Immunol (2010) 1.09
NKG2D ligand MICA is retained in the cis-Golgi apparatus by human cytomegalovirus protein UL142. J Virol (2009) 1.09
Inhibitors of nucleotidyltransferase superfamily enzymes suppress herpes simplex virus replication. Antimicrob Agents Chemother (2014) 0.95
Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol (2009) 0.92
Oncomodulation by human cytomegalovirus: novel clinical findings open new roads. Med Microbiol Immunol (2010) 0.91
Human immunodeficiency virus: 25 years of diagnostic and therapeutic strategies and their impact on hepatitis B and C virus. Med Microbiol Immunol (2009) 0.91
Margaret Gladys Smith, mother of cytomegalovirus: 60th anniversary of cytomegalovirus isolation. Med Microbiol Immunol (2015) 0.89
Human cytomegalovirus infection is associated with essential hypertension in Kazakh and Han Chinese populations. Med Sci Monit (2014) 0.89
Mast cells as rapid innate sensors of cytomegalovirus by TLR3/TRIF signaling-dependent and -independent mechanisms. Cell Mol Immunol (2014) 0.88
Resistance of human cytomegalovirus to cyclopropavir maps to a base pair deletion in the open reading frame of UL97. Antimicrob Agents Chemother (2013) 0.88
Approved Antiviral Drugs over the Past 50 Years. Clin Microbiol Rev (2016) 0.88
The history of vaccination against cytomegalovirus. Med Microbiol Immunol (2015) 0.86
Small bowel perforation due to CMV enteritis infection in an HIV-positive patient. BMC Res Notes (2013) 0.86
Murine cytomegalovirus immune evasion proteins operative in the MHC class I pathway of antigen processing and presentation: state of knowledge, revisions, and questions. Med Microbiol Immunol (2012) 0.86
Human cytomegalovirus UL34 binds to multiple sites within the viral genome. J Virol (2013) 0.84
Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion. J Biomed Biotechnol (2010) 0.83
A spatial view of the CD8+ T-cell response: the case of HCV. Rev Med Virol (2011) 0.79
Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance. Front Immunol (2016) 0.78
Metabolism of cyclopropavir and ganciclovir in human cytomegalovirus-infected cells. Antimicrob Agents Chemother (2014) 0.78
Cytomegalovirus enteritis with ischemia in an immunocompetent patient: A rare case report. Int J Surg Case Rep (2015) 0.77
Identification of an atypical CD8 T cell epitope encoded by murine cytomegalovirus ORF-M54 gaining dominance after deletion of the immunodominant antiviral CD8 T cell specificities. Med Microbiol Immunol (2015) 0.76
Nontraditional localization and retention signals localize human cytomegalovirus pUL34 to the nucleus. J Virol (2013) 0.76
Virus reactivation: a panoramic view in human infections. Future Virol (2011) 0.76
Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell Transplantation. Front Immunol (2016) 0.76
Disseminated cytomegalovirus infection and protein losing enteropathy as presenting feature of pediatric patient with Crohn's disease. Pediatr Gastroenterol Hepatol Nutr (2015) 0.75
Tales from the crypt and coral reef: the successes and challenges of identifying new herpesviruses using metagenomics. Front Microbiol (2015) 0.75
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers. Antimicrob Agents Chemother (2016) 0.75
Cytomegalovirus related fatal duodenal diverticular bleeding: Case report and literature review. World J Gastroenterol (2016) 0.75
Lack of XBP-1 impedes murine cytomegalovirus gene expression. PLoS One (2014) 0.75
Seropositivity of cytomegalovirus in patients with recurrent pregnancy loss. J Res Med Sci (2014) 0.75
Intestinal perforation due to hemorrhagic Cytomegalovirus enteritis in a patient with severe uncontrolled lupus nephritis: a case and review of the literature. Rheumatol Int (2017) 0.75
Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool. Med Microbiol Immunol (2016) 0.75
Die Another Day: Inhibition of Cell Death Pathways by Cytomegalovirus. Viruses (2017) 0.75
FK 506 for liver, kidney, and pancreas transplantation. Lancet (1989) 13.70
Intranuclear and Cytoplasmic Inclusions ("Protozoan-Like Bodies") in the Salivary Glands and Other Organs of Infants. Am J Pathol (1932) 9.01
Cytopathogenic agent resembling human salivary gland virus recovered from tissue cultures of human adenoids. Proc Soc Exp Biol Med (1956) 7.35
Cultivation of the Lansing Strain of Poliomyelitis Virus in Cultures of Various Human Embryonic Tissues. Science (1949) 7.29
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Cytomegalovirus as a possible cause of a disease resembling infectious mononucleosis. Br Med J (1965) 6.04
Intranuclear Inclusions in Visceral Disease. Am J Pathol (1925) 4.31
Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med (2001) 3.90
Serial propagation in vitro of agents producing inclusion bodies derived from varicella and herpes zoster. Proc Soc Exp Biol Med (1953) 3.78
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group. J Infect Dis (1992) 3.61
Cytomegalovirus disease in renal allograft recipients: a prospective study of the clinical features, risk factors and impact on renal transplantation. Medicine (Baltimore) (1980) 3.42
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants. J Pediatr (1981) 3.42
Serologic differentiation of viruses responsible for cytomegalic inclusion disease. Virology (1960) 3.36
Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis (1986) 3.31
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Generalized cytomegalic inclusion disease. J Pediatr (1950) 2.75
Latent cytomegalovirus infection in blood donors. Br Med J (1969) 2.61
Cytomegalovirus mononucleosis with jaundice as presenting sign. Lancet (1966) 2.59
Unique spectrum of activity of 9-[(1,3-dihydroxy-2-propoxy)methyl]-guanine against herpesviruses in vitro and its mode of action against herpes simplex virus type 1. Proc Natl Acad Sci U S A (1983) 2.54
Detection of human cytomegalovirus in plasma of AIDS patients during acute visceral disease by DNA amplification. J Clin Microbiol (1992) 2.44
Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis (2004) 2.29
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis (1991) 2.25
Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med (1973) 2.21
Primary infection with human cytomegalovirus: virus isolation from healthy infants and pregnant women. Am J Epidemiol (1970) 2.14
Disseminated cytomegalovirus infection. Molecular analysis of virus and leukocyte interactions in viremia. J Clin Invest (1988) 2.05
Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol Med (1957) 2.05
Cytomegalovirus immune globulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N Engl J Med (1986) 1.99
Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease. Proc Soc Exp Biol Med (1956) 1.94
Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine. Ann Intern Med (1985) 1.83
Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence. Clin Infect Dis (2005) 1.74
Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med (1988) 1.72
Latent and persistent infections of monocytes and macrophages. Intervirology (1996) 1.61
Cerebral involvement with advanced periventricular calcification in generalized cytomegalic inclusion disease in the newborn; a clinicopathological report of a case diagnosed during life. J Neuropathol Exp Neurol (1954) 1.58
Review. Cytomegaloviruses: the difficult years. J Infect Dis (1970) 1.46
Neurologic prognosis of cytomegalovirus polyradiculomyelopathy in AIDS. Neurology (1993) 1.45
Cytomegalovirus infection in sex partners: evidence for sexual transmission. J Infect Dis (1985) 1.42
9-(1,3-Dihydroxy-2-propoxymethyl)guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.34
Multicenter seroepidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation (1985) 1.29
Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis (2001) 1.23
Multiple infections by cytomegalovirus in patients with acquired immunodeficiency syndrome: documentation by Southern blot hybridization. J Infect Dis (1984) 1.22
A new laboratory aid in the clinical diagnosis of inclusion disease of infancy. Am J Clin Pathol (1952) 1.18
Venereal causes of cytomegalovirus mononucleosis. JAMA (1977) 1.13
Infection with cytomegalovirus in homosexual men. Br J Vener Dis (1984) 1.08
Cytomegalovirus infections in homosexual men. An epidemiological study. Ann Intern Med (1983) 1.06
Cytomegalovirus infection in homosexual men. Relationship to sexual practices, antibody to human immunodeficiency virus, and cell-mediated immunity. Am J Med (1987) 1.01
Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis (2004) 0.99
Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS). Neurology (1994) 0.98
Cytomegalovirus infection in children undergoing open-heart surgery. Yale J Biol Med (1976) 0.97
Infections in heart-lung transplant recipients. Transplantation (1986) 0.95
Widespread presence of cytomegalovirus DNA in tissues of healthy trauma victims. J Clin Pathol (1997) 0.89
Treatment of cytomegalovirus pneumonia with 9-[2-hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine and high-dose corticosteroids. Ann Intern Med (1986) 0.85
Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease. Br J Ophthalmol (1999) 0.79
[Etiology of cytomegaly in infants]. Schweiz Med Wochenschr (1953) 0.78
Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis (1992) 0.77
Recent advances in the diagnosis of cytomegalovirus infection. Ann Biol Clin (Paris) (1996) 0.77